Inhaled Isopropyl Alcohol for Treatment of Nausea
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age7-17
SponsorState University of New York at Buffalo
About this trial
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
Eligibility criteria
Qualifiers
Patients with a chief complaint of nausea or vomiting
Ages 7-178 years, both sexes
Weight ≥ 15 kg
Baxter Animated Retching Faces (BARF) nausea severity score ≥ 4/10
Disqualifiers
1. Require IV access
Inability to breathe in/out through the nose
Anosmia (self- or parental report)
Allergy to isopropyl alcohol or ondansetron
Trial design
Treatments tested in this trial
- Inhaled Isopropyl Alcohol
- Oral Ondansetron
- Inhaled Placebo
Treatment groups
84 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov